The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis

被引:166
作者
Sacre, Sandra M.
Andreakos, Evangelos
Kiriakidis, Serafim
Amjadi, Parisa
Lundberg, Anna
Giddins, Grey
Feldmann, Marc
Brennan, Fionula
Foxwell, Brian M.
机构
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England
[2] Royal United Hosp, Dept Orthoped, Bath BA1 3NG, Avon, England
基金
英国惠康基金;
关键词
D O I
10.2353/ajpath.2007.060657
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The widespread distribution of Toll-like receptors (TLRs) and their ligands raises the question whether they contribute to the production of inflammatory and tissue destructive molecules in rheumatoid arthritis (RA). We examined the expression and function of TLR2 and TLR4 and their downstream signaling adaptors MyD88 and Mal/TIRAP in synovial membrane cultures from RA tissue. Both TLR2 and TLR4 were detected by flow cytometry, and stimulation with TLR2 and TLR4 ligands augmented the spontaneous production of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8, indicating that TLR2 and TLR4 are functional in these cultures. In addition, overexpression of dominant-negative forms of MyD88 and Mal/TIRAP significantly down-regulated the spontaneous production of cytokines tumor necrosis factor-alpha, IL-6, and vascular endothelial growth factor, and enzymes MMP-1, MMP-2, MMP-3, and MMP-13 in RA synovial membrane cell cultures. Because TLR2 and TLR4 require both MyD88 and Mal/TIRAP for signaling, this study suggests that TLR function may regulate the expression of these factors in the RA synovium. Conditioned media from synovial membrane cell cultures stimulated human macrophages; in a MyD88- and Mal-dependent manner, suggesting the release of a TLR ligand(s) from these cells. Thus, TLRs not only protect against infection but may also promote the inflammatory and destructive process in RA.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 37 条
[1]  
ANCREAKOS E, 2004, BLOOD, V103, P2229
[2]   Heterogeneous requirement of IκB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis -: Implications for therapy [J].
Andreakos, E ;
Smith, C ;
Kiriakidis, S ;
Monaco, C ;
de Martin, R ;
Brennan, FM ;
Paleolog, E ;
Feldmann, M ;
Foxwell, BM .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1901-1912
[3]   IκB kinase 2 but not NF-κB-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction [J].
Andreakos, E ;
Smith, C ;
Monaco, C ;
Brennan, FM ;
Foxwell, BM ;
Feldmann, M .
BLOOD, 2003, 101 (03) :983-991
[4]   Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators [J].
Bondeson, J ;
Foxwell, B ;
Brennan, F ;
Feldmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5668-5673
[5]  
BOTTAZZO GF, 1983, LANCET, V2, P1115
[6]  
BRENNAN FM, 1989, LANCET, V2, P244
[7]   CYTOKINE PRODUCTION IN CULTURE BY CELLS ISOLATED FROM THE SYNOVIAL-MEMBRANE [J].
BRENNAN, FM ;
CHANTRY, D ;
JACKSON, AM ;
MAINI, RN ;
FELDMANN, M .
JOURNAL OF AUTOIMMUNITY, 1989, 2 :177-186
[8]   RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3 [J].
Brentano, F ;
Schorr, O ;
Gay, RE ;
Gay, S ;
Kyburz, D .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2656-2665
[9]   TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation [J].
Cottalorda, Anne ;
Verschelde, Claire ;
Marcais, Antoine ;
Tomkowiak, Martine ;
Musette, Philippe ;
Uematsu, Satoshi ;
Akira, Shizuo ;
Marvel, Jacqueline ;
Bonnefoy-Berard, Nathalie .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (07) :1684-1693
[10]   Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].
Feldmann, M ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196